INTRODUCTION

Rationale
3 Describe the rationale for the review in the context of what is already known, including mention of why a network meta-analysis has been conducted.
7
Objectives 4 Provide an explicit statement of questions being addressed, with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).
METHODS
Protocol and registration 5
Indicate whether a review protocol exists and if and where it can be accessed (e.g., Web address); and, if available, provide registration information, including registration number. 
9
Data collection process 10 Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.
Data items 11 List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.
Additional File 1
Geometry of the network S1 Describe methods used to explore the geometry of the treatment network under study and potential biases related to it. This should include how the evidence base has been graphically summarized for presentation, and what characteristics were compiled and used to describe the evidence base to readers.
10-12
Risk of bias within individual studies 12 Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis. 
9-10 (see also
11-12
RESULTS †
Study selection 17 Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.
13 and Figure  1 Presentation of network structure S3 Provide a network graph of the included studies to enable visualization of the geometry of the treatment network.
Figure 2
Summary of network geometry S4 Provide a brief overview of characteristics of the treatment network. This may include commentary on the abundance of trials and randomized patients for the different interventions and pairwise comparisons in the network, gaps of evidence in the treatment network, and potential biases reflected by the network structure.
14-18
Study characteristics 18 For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations. 
26-27
Abbreviations: PICOS -population, intervention, comparators, outcomes, study design * Text in italics indicates wording specific to reporting of network meta-analyses that has been added to guidance from the PRISMA statement. † Authors may wish to plan for use of appendices to present all relevant information in full detail for items in this section.
